Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
- First Posted Date
- 2012-12-13
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- NeurAxon Inc.
- Target Recruit Count
- 188
- Registration Number
- NCT01748877
- Locations
- ๐บ๐ธ
Neurological Research Institute, Santa Monica, California, United States
๐บ๐ธFPA Clinical Research, Kissimmee, Florida, United States
๐จ๐ฆManna Research, Inc., Toronto, Ontario, Canada
Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2014-07-23
- Lead Sponsor
- NeurAxon Inc.
- Target Recruit Count
- 195
- Registration Number
- NCT00959751
- Locations
- ๐บ๐ธ
Comprehensive Neuroscience, Inc., St. Petersburg, Florida, United States
๐บ๐ธElkind Headache Center, Mount Vernon, New York, United States
๐บ๐ธComprehensive NeuroScience, Inc. Atlanta, Atlanta, Georgia, United States
Study of NXN 188 for the Treatment of Migraine With Aura
Phase 2
Completed
- Conditions
- Migraine With Aura
- Interventions
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2014-08-11
- Lead Sponsor
- NeurAxon Inc.
- Target Recruit Count
- 239
- Registration Number
- NCT00920686
- Locations
- ๐บ๐ธ
The Research Center of Southern California, LLC, Oceanside, California, United States
๐บ๐ธC. Philip O'Carrroll, MD, Inc., Newport Beach, California, United States
๐บ๐ธSan Francisco Headache Clinic, San Francisco, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath